NeuroPace (NPCE) Short-term Investments (2020 - 2026)

NeuroPace's Short-term Investments history runs 7 years deep, the most recent figure standing at $39.2 million for Q1 2026.

• In Q1 2026, Short-term Investments changed 0.1% year-over-year to $39.2 million; the TTM figure through Mar 2026 stood at $39.2 million (changed 0.1% YoY), while the FY2025 annual figure was $39.4 million, changed 0.1% from the prior year.
• Short-term Investments was $39.2 million for Q1 2026 at NeuroPace, roughly flat from $39.4 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $95.7 million in Q1 2022 to a low of $39.2 million in Q1 2026.
• Historically, Short-term Investments has averaged $53.8 million across 5 years, with a median of $45.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments jumped 473.35% in 2022, then tumbled 36.36% in 2023.
• A 5-year view of Short-term Investments shows it stood at $70.8 million in 2022, then plunged by 31.65% to $48.4 million in 2023, then slipped by 18.74% to $39.3 million in 2024, then climbed by 0.1% to $39.4 million in 2025, then declined by 0.42% to $39.2 million in 2026.
• The last three Short-term Investments figures came in at $39.2 million (Q1 2026), $39.4 million (Q4 2025), and $39.4 million (Q3 2025), per Business Quant data.